Cicatricial pemphigoid: Immunopathogenesis and treatment

Dermatologic Therapy

Volumn 15, Issue 4, 2002, Pages 382-388

  Lazarova, Zelmira ^a   Yancey, Kim B ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Autoimmunity; Basement membrane; Bullous disease; Pemphigoid; Therapy

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; DAPSONE; DIPHENHYDRAMINE; DYCLONINE; GLUCOCORTICOID; IMMUNOGLOBULIN; LIDOCAINE; MITOMYCIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; TETRACYCLINE; TRIAMCINOLONE ACETONIDE;

AUTOIMMUNITY; BASEMENT MEMBRANE; BLADDER CANCER; BLISTER; BONE MARROW SUPPRESSION; BULLOUS DERMATITIS; DISEASE ASSOCIATION; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNOPATHOGENESIS; LYMPHOMA; MORBIDITY; MORTALITY; MUCOSA; MUCOUS MEMBRANE PEMPHIGOID; PAIN; PATHOPHYSIOLOGY; PEMPHIGOID; PHENOTYPE; PLASMAPHERESIS; REVIEW; SCAR; TISSUE INJURY;

EID: 0036969393     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1529-8019.2002.01549.x     Document Type: Review

References (67)

1. Lever WF. Pemphigus and pemphigoid. Springfield, IL: Charles C. Thomas, 1965.
2. Sneddon IB. Cicatricial pemphigoid and skin grafts. Arch Dermatol 1962: 86: 226-228.
3. Hardy KM, Perry HO, Pingree GC, Kirby TJ. Benign mucous membrane pemphigoid. Arch Dermatol 1971: 104: 467-475.
4. Person JR, Rogers RS. Bullous and cicatricial pemphigoid: clinical, histopathologic, and immunopathologic correlations. Mayo Clin Proc 1977: 52: 54-66.
5. Williams DM, Leonard JN, Wright P, et al. Benign mucous membrane (cicatricial) pemphigoid: a clinical and immunological reappraisal. Br Dent J 1984: 157: 313-316.
6. Rogers RS, Perry HO, Bean SF, Jordon RE. Immunopathology of cicatricial pemphigoid: studies of complement deposition. J Invest Dermatol 1977: 68: 39-43.
7. Fleming MG, Valenzuela R, Bergfeld WF, Tuthill RJ. Mucous gland basement membrane immunofluorescence in cicatricial pemphigoid. Arch Dermatol 1988: 124: 1407-1410.
8. Siegel MA, Anhalt GJ. Direct immunofluorescence of detached gingival epithelium for diagnosis of cicatricial pemphigoid. Oral Surg Oral Med Oral Pathol 1993: 75: 296-302.
9. Laskaris G, Angelopoulos A. Cicatricial pemphigoid: direct and indirect immunofluorescence studies. Oral Surg Oral Med Oral Pathol 1981: 51: 48-54.
10. Kelly SE, Wojnarowska F. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Br J Dermatol 1988: 118: 31-40.
11. Sarret Y, Hall R, Cobo LM, Thivolet J, Patton DL, Woodley DT. Salt-split human skin substrate for the immunofluorescent screening of serum from patients with cicatricial pemphigoid and a new method of immunoprecipitation with IgA antibodies. J Am Acad Dermatol 1991: 24: 952-958.
12. Korman NJ, Watson RD. Immune-mediated subepidermal blistering diseases of the mucous membranes: improving the detection of circulating autoantibodies by the use of concentrated serum samples. Arch Dermatol 1996: 132: 1194-1198.
13. Lazarova Z, Yancey KB. The reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1M NaCl split skin: specificity, sensitivity and practical considerations. J Am Acad Dermatol 1996: 35: 398-403.
14. Shimizu H, Masunaga T, Ishiko A, et al. Autoantibodies from patients with cicatricial pemphigoid target different sites in epidermal basement membrane. J Invest Dermatol 1995: 104: 370-373.
15. Bernard P, Vaillant L, Labeille B, et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 1995: 131: 48-52.
16. Zillikens D, Wever S, Roth A, Hashimoto T, Brocker EB. Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 1995: 131: 957-958.
17. Zaltas MM, Ahmed R, Foster CS. Association of HLA-DR4 with ocular cicatricial pemphigoid. Curr Eye Res 1989: 8: 189-193.
18. Ahmed AR, Foster S, Zaltas M, et al. Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid. Proc Natl Acad Sci USA 1991: 15: 11579-11582.
19. Yunis JJ, Mobini N, Yunis EJ, et al. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid. Proc Natl Acad Sci USA 1994: 91: 7747-7751.
20. Delgado JG, Turbay D, Yunis EJ, et al. A common major histocompatibility complex class II allele. HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci USA: 1996: 93: 8569-8571.
21. Lever WF. Pemphigus. Medicine 1953: 32: 1-123.
22. Shklar G, McCarthy PL. Oral lesions of mucous membrane pemphigoid. Arch Otolaryngol 1971: 93: 354-364.
23. McCarthy PL, Shklar G. Benign mucous membrane pemphigus. N Engl I Med 1958: 258: 726-731.
24. Brauner GJ, Jimbow K. Benign mucous membrane pemphigoid: an unusual case with electron microscopic findings. Arch Dermatol 1972: 106: 535-540.
25. Foster CS, Shaw CD, Wells PA. Scanning electron microscopy of conjunctival surfaces in patients with ocular cicatricial pemphigoid. Am J Ophthalmol 1986: 102: 584-591.
26. Bedane C, Prost C, Bernard P, Catanzo G, Bonnetblanc JM, Dubertret L. Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immunoelectron microscopy. J Invest Dermatol 1991: 97: 3-9.
27. Luke MC, Darling TN, Hsu R, et al. Mucosal morbidity in patients with epidermolysis bullosa acquisita. Arch Dermatol 1999: 135: 954-959.
28. Griffith MR, Fukuyama K, Tufanelli D, Silverman S. Immunofluorescence studies in mucous membrane pemphigoid. Arch Dermatol 1974: 109: 195-199.
29. Leonard JN, Hobday CM, Haffenden GP, et al. Immunofluorescent studies in ocular cicatricial pemphigoid. Br J Dermatol 1988: 118: 209-217.
30. Bernard PB, Prost C, Durepaire N, Basset-Sequin N, Didierjean L, Saurat JH. The major cicatricial pemphigoid antigen is a 180 kD protein that shows immunologic cross-reactivity with bullous pemphigoid antigen. J Invest Dermatol 1992: 99: 174-179.
31. Hirako Y, Usukura J, Nishizawa Y, Owaribe K. Demonstration of the molecular shape of BP180, a 180-kDa bullous pemphigoid antigen and its potential for trimer formation. J Biol Chem 1996: 271: 13739-13745.
32. Masunaga T, Shimizu H, Yee C, et al. The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane. J Invest Dermatol 1997: 109: 200-206.
33. Balding SD, Prost C, Diaz LA, et al. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 1996: 106: 141-146.
34. Bedane C, McMillan JR, Balding SD, et al. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol 1997: 108: 901-907.
35. Domloge-Hultsch N, Gammon WR, Briggaman RA, Gil SG, Carter WG, Yancey KB. Epiligrin, the major human keratinocyte ligand, is a target in both an acquired autoimmune and inherited subepidermal disease. J Clin Invest 1992: 90: 1628-1633.
36. Domloge-Hultsch N, Anhalt GJ, Gammon WR, et al. Anti-epiligrin cicatricial pemphigoid: a subepithelial bullous disorder. Arch Dermatol 1994: 130: 1521-1529.
37. Kirtschig G, Marinkovich MP, Burgeson RE, Yancey KB. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J Invest Dermatol 1995: 105: 543-548.
38. Hsu R, Lazarova Z, Yee C, Yancey KB. Noncomplement fixing, IgG4 autoantibodies predominate in patients with anti-epiligrin cicatricial pemphigoid. J Invest Dermatol 1997: 109: 557-561.
39. Lazarova Z, Hsu R, Yee C, Yancey KB. Anti-epiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (α3β3γ2). Br J Dermatol 1998: 139: 791-797.
40. Lazarova Z, Yee C, Lazar J, Yancey KB. IgG autoantibodies in patients with anti-epiligrin cicatricial pemphigoid recognize the G domain of the laminin 5 α subunit. J Clin Immunol 2001: 101: 100-105.
41. Chan LS, Majmudar AA, Tran HH, et al. Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. J Invest Dermatol 1997: 108: 848-853.
42. Lazarova Z, Yee C, Darling T, Briggaman RA, Yancey KB. Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J Clin Invest 1996: 98: 1509-1518.
43. Lazarova Z, Hsu R, Briggaman RA, Yancey KB. Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice. Clin Immunol 2000: 95: 26-32.
44. Lazarova Z, Hsu R, Yee C, Yancey KB. Human anti-laminin 5 antibodies induce subepidermal blisters in an experimental skin graft model. I Invest Dermatol 2000: 114: 178-184.
45. Mohimen A, Neumann R, Foster CS, Ahmed AR. Detection and partial characterization of ocular cicatricial pemphigoid antigens on COLO and SCABER tumor cell lines. Curr Eye Res 1993: 12: 741-752.
46. Tyagi S, Bhol K, Natarajan K, Livir-Rallatos C, Foster CS, Ahmed AR. Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci USA 1996: 93: 14714-14719.
47. 4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 1999: 40: 2283-2290.
48. Ghohestani RF, Nicolas JF, Rousselle P, Claudy AL. Identification of a 168-kDa mucosal antigen in a subset of patients with cicatricial pemphigoid. J Invest Dermatol 1996: 107: 136-139.
49. Egan CA, Lazarova Z, Darling TN, Yee C, Cote T, Yancey KB. Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet 2001: 357(9271): 1850-1851.
50. Yancey K. Cicatricial pemphigoid. In: Freedberg I, Eisen A, Wolff K, et al, eds. Dermatology in general medicine. 5th ed. New York: McGraw-Hill, 1999: 674-679.
51. Fleming TE, Korman NJ. Cicatricial pemphigoid. I Am Acad Dermatol 2000: 43: 571-591.
52. Egan CA, Yancey KB. The clinical and immunopathological manifestations of anti-epiligrin cicatricial pemphigoid, a recently defined subepithelial autoimmune blistering disease. Eur J Dermatol 2000: 10: 585-589.
53. Wal VB, Jonkman MF. Topical tetracycline in cicatricial pemphigoid. J Am Acad Dermatol 1997: 36: 492-493.
54. Eisen D, Ellis CN, Voorhees JJ. Topical cyclosporin for oral bullous disorders. J Am Acad Dermatol 1990: 23: 936-937.
55. Letko E, Ahmed AR, Foster CS. Treatment of ocular cicatricial pemphigoid with tacrolimus (FK 506). Graefes Arch Clin Exp Ophthalmol 2001: 239: 441-444.
56. Holland EJ, Olsen TW, Ketcham JM, et al. Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea 1993: 12: 413-419.
57. Donnenfeld ED, Perry HD, Wallerstein A, et al. Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid. Ophthalmology 1999: 106: 72-78.
58. Foster CS, Wilson LA, Ekins MB. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology 1982: 89: 340-353.
59. Rogers RS, Seehafer JR, Perry HO. Treatment of cicatricial pemphigoid (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol 1986: 6: 215-223.
60. Tauber J, Sainz de la Maza M, Foster CS. Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea 1991: 10: 185-195.
61. Nguyen QD, Foster CC. Cicatricial pemphigoid: diagnosis and treatment. Int Ophthalmol Clin 1996: 36: 41-60.
62. Korman NJ. Update on the use of azathioprine in the management of pemphigus and bullous pemphigoid. Med Surg Dermatol 1996: 3: 209-213.
63. Korman NJ. Update on the use of cyclophosphamide in the management of pemphigus, bullous pemphigoid and cicatricial pemphigoid. Med Surg Dermatol 1998: 5: 1-6.
64. Pandya AG, Waren KJ, Bergstresser PR. Cicatricial pemphigoid successfully treated with pulse intravenous cyclophosphamide. Arch Dermatol 1997: 133: 245-247.
65. Urcelay ML, McQueen A, Douglas WS. Cicatricial pemphigoid treated with intravenous immunoglobulin. Br J Dermatol 1997: 137: 477-478.
66. Bohn J, Benfeldt E, Dabelsteen E, Menne T. Treatment of ocular cicatricial pemphigoid with intravenous gammaglobulin. Acta Derm Venereol (Stockh) 1998: 78: 316-317.
67. Foster CS, Ahmed AR. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study. Ophthalmology 1999: 106: 2136-2143.